Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FB3KV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,886
Award facts
- Contract value 100% obligated
- $13,886.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $13,886.20 by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Nexplanon 68 mg implants. The contract, with an ultimate completion date of September 24, 2025, does not utilize a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499,999,999 contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide.
As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established a robust portfolio of delivery orders with the DLA covering diverse medical products ranging from contraceptive devices and oncology treatments to vaccines and specialty medications. The Nexplanon implant, a long-acting reversible contraceptive device, represents one component of the company's extensive offerings to military health facilities. The delivery order pricing structure reflects the firm fixed-price model typical of DLA pharmaceutical procurement, ensuring cost certainty for government healthcare operations while leveraging DMS Pharmaceutical Group's established distribution capabilities and SAM.gov registration since 2001.
Quick answers
Who was awarded contract SPE2DB25FB3KV?
SPE2DB25FB3KV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FB3KV worth?
The government has obligated $13,886 on SPE2DB25FB3KV.
Is contract SPE2DB25FB3KV an order under another contract?
Yes. SPE2DB25FB3KV is a delivery order under SPE2DB20D9761, an indefinite delivery contract.
Was contract SPE2DB25FB3KV competed?
The extent of competition for SPE2DB25FB3KV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award